 "Advanced Enzyme zooms over 25% in one week as promoter increases stakes")
Advanced Enzyme Technologies moved higher by 10% to Rs 2,195, extending its 16% rally in past four trading days on the National Stock Exchange (NSE), after the promoter increased their stake in the company through open market purchase.
In past two trading sessions, Chandrakant Rathi Innovations and Projects Private Limited had bought 480,747 equity shares representing 2.2% stake of Advanced Enzyme Technologies via open market transactions on NSE.
On March 20, 2017, Chandrakant Rathi Innovations and Projects Private Limited bought 320,724 shares at price of Rs 1,957.76 and additional, 160,023 shares at Rs 1,988.16 on March 21, the NSE bulk deal data shows. CLICK HERE FOR DETAILS
The name of the sellers was not ascertained immediately.
As of December 31, 2016, Chandrakant Rathi Innovations and Projects Private Limited held 17.45 stake of the total promoters holding of 66.50% in Advanced Enzyme Technologies.
In past two weeks, the stock zoomed 36% as compared to 0.84% rise in the Nifty 50 index. Thus far in the calendar year 2017, it underperformed the market and fell 19% as compared to 8.6% rise in the benchmark index, till March 8, 2017.
At 03:00 pm; the stock was up 8.4% at Rs 2,167 against 0.98% decline in the Nifty 50 index. A combined 1.5 million shares changed hands on the counter on the NSE and BSE so far.
In past two trading sessions, Chandrakant Rathi Innovations and Projects Private Limited had bought 480,747 equity shares representing 2.2% stake of Advanced Enzyme Technologies via open market transactions on NSE.
On March 20, 2017, Chandrakant Rathi Innovations and Projects Private Limited bought 320,724 shares at price of Rs 1,957.76 and additional, 160,023 shares at Rs 1,988.16 on March 21, the NSE bulk deal data shows. CLICK HERE FOR DETAILS
The name of the sellers was not ascertained immediately.
As of December 31, 2016, Chandrakant Rathi Innovations and Projects Private Limited held 17.45 stake of the total promoters holding of 66.50% in Advanced Enzyme Technologies.
In past two weeks, the stock zoomed 36% as compared to 0.84% rise in the Nifty 50 index. Thus far in the calendar year 2017, it underperformed the market and fell 19% as compared to 8.6% rise in the benchmark index, till March 8, 2017.
At 03:00 pm; the stock was up 8.4% at Rs 2,167 against 0.98% decline in the Nifty 50 index. A combined 1.5 million shares changed hands on the counter on the NSE and BSE so far.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%